Literature DB >> 2085747

Anatomical mapping of brain sites involved in the antinociceptive effects of ketoprofen.

R de Beaurepaire1, C Suaudeau, A Chait, C Cimetière.   

Abstract

Ketoprofen, a non-steroidal anti-inflammatory drug, has analgesic effects in animals and humans through a peripheral as well as a central action. This study was designed to determine which brain sites are involved in the central analgesic action of ketoprofen, by using the hot-plate test. Latencies to the first hindpaw lick were recorded in animals receiving local cerebral injections of ketoprofen (10 micrograms in 0.3 microliters) or a control solution (saline). Nineteen brain sites were tested. A significant analgesia was obtained in the 8 following sites: central gray, centro-medial nucleus of the thalamus, nucleus reuniens, dorso-lateral geniculate nucleus, medial geniculate nucleus, dorso-medial and ventro-medial nuclei of the hypothalamus, posterior hypothalamic nucleus and lateral vestibular nucleus. A slight analgesia, which did not reach significance, was observed in three structures: dorsal raphé, raphé magnus and ventral postero-medial thalamic nucleus. No analgesia was observed in other sites: centro-lateral nucleus of the thalamus, posterior thalamic nuclear group, parafascicular nucleus, bed nucleus of the stria terminalis, mesencephalic tegmentum, nucleus of the tractus solitarius, spinal trigeminal complex, and brainstem reticular formation. Therefore ketoprofen seems to be centrally active mostly at the level of several integrative and non-specific structures.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085747     DOI: 10.1016/0006-8993(90)90026-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Management of Inflammatory Pain with Selective COX-2 Inhibitors: Promises and Facts.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

2.  Interaction between the antinociceptive effect of ketoprofen and adrenergic modulatory systems.

Authors:  G Pinardi; F Sierralta; H F Miranda
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

3.  Pharmacokinetics and Pharmacodynamics of (S)-Ketoprofen Co-Administered with Caffeine: A Preclinical Study in Arthritic Rats.

Authors:  Raúl Medina-López; Nancy Vara-Gama; Olivia Soria-Arteche; Luis A Moreno-Rocha; Francisco J López-Muñoz
Journal:  Pharmaceutics       Date:  2018-01-26       Impact factor: 6.321

4.  Pharmacokinetic Evaluation of a Novel Transdermal Ketoprofen Formulation in Healthy Dogs.

Authors:  Halley Gora Ravuri; Nana Satake; Alexandra Balmanno; Jazmine Skinner; Samantha Kempster; Paul C Mills
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.